Ligand validation:5NLR

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 5NLR designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5NLR_NAG_A_302	51%	29%	0.147	0.9	0.82	2	1	8	0	0	100%	1
5ACH_NAG_A_401	89%	58%	0.088	0.967	0.76	0.86	-	-	0	0	100%	1
5NKW_NAG_A_302	79%	29%	0.098	0.943	1.28	1.57	2	3	0	0	100%	1
5NLO_NAG_A_302	78%	33%	0.106	0.947	1.38	1.27	1	2	0	0	100%	1
7PXV_NAG_A_302	77%	56%	0.103	0.942	0.47	1.2	-	1	0	0	100%	1
5NLQ_NAG_A_302	77%	51%	0.112	0.951	0.77	1.13	-	1	0	0	100%	1
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	1
5F9W_NAG_A_510	100%	88%	0.023	0.994	0.24	0.43	-	-	0	0	100%	1
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	1
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	1
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.